Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Here's Why It Is Wise To Hold On To Blackstone (BX) Stock Now

Published 06/18/2019, 07:28 AM
Updated 07/09/2023, 06:31 AM

The Blackstone Group L.P. (NYSE:BX) remains well positioned for growth given its revenue mix, inorganic growth efforts and continued asset inflows. Moreover, the company's decision to convert itself from a publicly traded partnership to a corporation will likely help attract more investors for its stock.

The Zacks Consensus Estimate for its current-year earnings has been marginally revised upward over the past 30 days, reflecting that analysts are optimistic regarding Blackstone’s earnings growth prospects.

Moreover, shares of the company have gained 60.2% in the past six months, outpacing 18.9% growth recorded by the industry it belongs to.




However, persistently mounting costs are likely to hurt Blackstone’s bottom-line growth. In addition, sustainability of the company's capital deployment actions is low. Thus, the stock currently carries a Zacks Rank #3 (Hold).

Looking at its fundamentals, revenues (GAAP basis) have witnessed a four-year (2015-2018) CAGR of 13.7%. This uptrend is expected to continue in the upcoming quarters, backed by better performance of its funds.

Furthermore, Blackstone’s fee-earning assets under management (AUM) as well as total AUM consistently demonstrate strong growth. Over the last four years (2015-2018), fee-earning AUM witnessed a CAGR of 11.6%, while total AUM recorded a CAGR of 12%. These were driven by increasing net inflows. In fact, given the company’s diversified products, revenue mix and superior position in the alternative investments space, growth in AUM is anticipated to continue.

However, elevated expenses are a concern for Blackstone. Costs have escalated at a four-year (2015-2018) CAGR of 4.4%. This upswing mainly stemmed from higher general, administrative and other expenses. Expenses are expected to continue rising as the company’s well-performing funds require more headcount and because of its continued investment in franchise.

Additionally, the company’s increased dependence on management and advisory fees for revenues may affect its financials, if it witnesses any change in the managed assets, regulations or a slowdown in business activities.

Some better-ranked stocks from the finance space are Hilltop Holdings Inc. (NYSE:HTH) , Cadence Bancorporation (NYSE:CADE) and First Bancorp (NASDAQ:FBNC) . Each of these currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Over the past 60 days, Hilltop Holdings witnessed an upward earnings estimate revision of 11.5% for the current year. Its share price has increased 17.2% in the past six months.

Cadence Bancorporation’s Zacks Consensus Estimate for 2019 has been revised 8.8% upward over the past 60 days. Its shares have gained nearly 13.7% in the past six months.

Over the past 60 days, First Bancorp witnessed an upward earnings estimate revision of 3% for the ongoing year. Its share price has rallied 12.7% in the past six months.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

First Bancorp (FBNC): Free Stock Analysis Report

The Blackstone Group L.P. (BX): Free Stock Analysis Report

Hilltop Holdings Inc. (HTH): Free Stock Analysis Report

Cadence Bancorp (CADE): Free Stock Analysis Report

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.